Soundwave therapy shows promise for chemo nerve damage
NCT ID NCT05980169
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called SensoniQ® Treatment Station that uses low frequency soundwaves to prevent or reduce nerve pain caused by chemotherapy in people with gynecologic cancer. The trial includes 80 participants, some starting chemo and others with lasting nerve pain. Researchers will measure changes in neuropathy symptoms using questionnaires and exams.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GYNECOLOGIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
James T Sonnenberg
Augusta, Georgia, 29607, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a personalized exercise program boost recovery in cancer survivors?
- Quitting before the knife: which Stop-Smoking aid works best for cancer patients?
- Braids and conditioner may boost scalp cooling against chemo hair loss
- New imaging tool could help surgeons detect hidden cancer cells during surgery
- Could an ALS drug clear the fog of chemo brain?
- Could a chatbot help close the gap in genetic cancer testing?